Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

2,409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers.
Rofi E, Del Re M, Arrigoni E, Rizzo M, Fontanelli L, Crucitta S, Gianfilippo G, Restante G, Fogli S, Porta C, Danesi R, Schmidinger M. Rofi E, et al. Among authors: rizzo m. Crit Rev Oncol Hematol. 2020 Oct;154:102891. doi: 10.1016/j.critrevonc.2020.102891. Epub 2020 Apr 25. Crit Rev Oncol Hematol. 2020. PMID: 32340783 Free article.
Targeting angiogenesis in metastatic renal cell carcinoma.
Canino C, Perrone L, Bosco E, Saltalamacchia G, Mosca A, Rizzo M, Porta C. Canino C, et al. Among authors: rizzo m. Expert Rev Anticancer Ther. 2019 Mar;19(3):245-257. doi: 10.1080/14737140.2019.1574574. Epub 2019 Feb 6. Expert Rev Anticancer Ther. 2019. PMID: 30678509 Review.
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions.
Incorvaia L, Fanale D, Badalamenti G, Porta C, Olive D, De Luca I, Brando C, Rizzo M, Messina C, Rediti M, Russo A, Bazan V, Iovanna JL. Incorvaia L, et al. Among authors: rizzo m. Oncoimmunology. 2020 Oct 27;9(1):1832348. doi: 10.1080/2162402X.2020.1832348. Oncoimmunology. 2020. PMID: 33178494 Free PMC article.
The basics of onco-nephrology in the renal clinic.
Cosmai L, Porta C, Foramitti M, Rizzo M, Gallieni M. Cosmai L, et al. Among authors: rizzo m. J Nephrol. 2020 Dec;33(6):1143-1149. doi: 10.1007/s40620-020-00922-x. J Nephrol. 2020. PMID: 33242211 Review.
2,409 results